Pharmaceutical Executive-06-01-2008
Pharmaceutical Executive
When it comes to marketing, every syllable speaks volumes
Pharmaceutical Executive
S
Pharmaceutical Executive
EU makes plans to police its supply chain
Pharmaceutical Executive
Everyone makes mistakes; how you handle them is the measure of a true leader
Pharmaceutical Executive
This time, powerful interest groups (like pharma) that sank the Clinton healthcare bill are on the side of change
Pharmaceutical Executive
Pharma is taking note of online video's power to affect B2B communications
Pharmaceutical Executive
The great debate on DTC advertising is heating up again. We're going to be hearing a lot about fair balance and risk communication and costs. But what about the patients?
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
